MARK CORRIGAN Insider Trading $CRXX EPIRUS Biopharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK CORRIGAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK CORRIGAN. MARK CORRIGAN is President & CEO in EPIRUS Biopharmaceuticals, Inc. ($CRXX).
MARK CORRIGAN in EPIRUS Biopharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK CORRIGAN: President & CEO
Holdings: 364,567 shares
Latest Transaction: Feb 12 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK CORRIGAN in EPIRUS Biopharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2014 | CRXX | EPIRUS Biopharmace ... | CORRIGAN MARK | President & CEO | Option Exercise | A | 1.47 | 250,000 | 367,500 | 250,000 | |
| Feb 12 2014 | CRXX | EPIRUS Biopharmace ... | CORRIGAN MARK | President & CEO | Grant | A | 0.00 | 250,000 | 0 | 364,567 | 114.6 K to 364.6 K (+218.21 %) |
| Jan 17 2014 | CRXX | EPIRUS Biopharmace ... | CORRIGAN MARK | President & CEO | Payment of Exercise | F | 1.66 | 18,079 | 30,011 | 114,567 | 132.6 K to 114.6 K (-13.63 %) |
| Jan 07 2014 | CRXX | EPIRUS Biopharmace ... | CORRIGAN MARK | President & CEO | Payment of Exercise | F | 1.22 | 8,035 | 9,803 | 132,646 | 140.7 K to 132.6 K (-5.71 %) |
| Jan 17 2013 | CRXX | EPIRUS Biopharmace ... | CORRIGAN MARK | President & CEO | Sell | S | 0.77 | 112,850 | 86,895 | 844,090 | 956.9 K to 844.1 K (-11.79 %) |
| Jan 07 2013 | CRXX | EPIRUS Biopharmace ... | CORRIGAN MARK | President & CEO | Option Exercise | A | 0.76 | 500,000 | 380,000 | 500,000 | |
| Jan 07 2013 | CRXX | EPIRUS Biopharmace ... | CORRIGAN MARK | President & CEO | Grant | A | 0.00 | 250,000 | 0 | 956,940 | 706.9 K to 956.9 K (+35.36 %) |
| Jan 27 2012 | CRXX | EPIRUS Biopharmace ... | CORRIGAN MARK | President & CEO | Option Exercise | A | 1.13 | 799,226 | 903,125 | 799,226 | |
| Jan 27 2012 | CRXX | EPIRUS Biopharmace ... | CORRIGAN MARK | President & CEO | Option Exercise | A | 1.13 | 100,774 | 113,875 | 100,774 | |
| Jan 19 2012 | CRXX | EPIRUS Biopharmace ... | CORRIGAN MARK | President & CEO | Sell | S | 1.14 | 68,105 | 77,640 | 706,940 | 775 K to 706.9 K (-8.79 %) |
| Feb 10 2011 | CRXX | EPIRUS Biopharmace ... | CORRIGAN MARK | President & CEO | Option Exercise | A | 2.65 | 300,000 | 795,000 | 300,000 | |
| Jan 20 2011 | CRXX | EPIRUS Biopharmace ... | CORRIGAN MARK | President & CEO | Sell | S | 2.18 | 62,160 | 135,509 | 775,045 | 837.2 K to 775 K (-7.42 %) |
Page: 1